Jeff Davis of Acer Therapeutics
joined us for World Orphan Drug Congress USA 2015 to present about '
Developing Therapeutics for the Treatment of (Ultra) Orphan Diseases With Significant Unmet Medical Needs'.
Download the presentation now to learn about:
-
Normal Branched-chain Amino Acid Metabolism
-
NaPBA: Scientific Rationale for Lowering Leucine
-
NaPBA: Clinical Proof-of-Concept Study in MSUD
-
ACER-001: Pivotal Study Design/Development Plan
...and
much
more!
Get your copy here!
To find out more about how
Acer Therapeutics is developing therapeutics for treatment of (ultra) orphan diseases
, join us at
World Orphan Drug Congress USA 2016 April 20-22
in Washington, DC.